The Sixth John M. Kinney-Nestlé Clinical Nutrition Award for Enteral Nutrition. Recombinant human tumor necrosis factor and recombinant murine interleukin-1 alter the binding of Escherichia coli to intestine, mucin glycoprotein, and the HT29-C1 intestinal cell line: a context.
Wanke
C A
CA
Tufts University School of Medicine, Boston, Massachusetts 02111, USA. cwanke@infonet.tufts.edu
D000818:Animals; D002460:Cell Line; D003967:Diarrhea / Q000150:complications / Q000382:microbiology; D004926:Escherichia coli / Q000378:metabolism*; D004927:Escherichia coli Infections; D015658:HIV Infections / Q000150:complications; D019073:HT29 Cells; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology*; D007422:Intestines / Q000382:microbiology*; D051379:Mice; D009077:Mucins / Q000378:metabolism*; D009747:Nutritional Physiological Phenomena; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D007375:Interleukin-1; D009077:Mucins; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha